au.\*:("MOUSSES, Spyro")
Results 1 to 20 of 20
Selection :
Integration of genomic technologies for accelerated cancer drug developmentBASIK, Mark; MOUSSES, Spyro; TRENT, Jeffrey et al.BioTechniques. 2003, Vol 35, Num 3, pp 580-593, issn 0736-6205, 8 p.Article
Identification of molecular markers for endometriosis in blood lymphocytes by using deoxyribonucleic acid microarraysFLORES, Idhaliz; RIVERA, Elizabeth; MOUSSES, Spyro et al.Fertility and sterility. 2006, Vol 85, Num 6, pp 1676-1683, issn 0015-0282, 8 p.Article
Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplificationKUUSELO, Riina; SAVINAINEN, Kimmo; AZORSA, David O et al.Cancer research (Baltimore). 2007, Vol 67, Num 5, pp 1943-1949, issn 0008-5472, 7 p.Article
PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutationTIBES, Raoul; KORNBLAU, Steven M; YIHUA QIU et al.British journal of haematology. 2008, Vol 140, Num 3, pp 344-347, issn 0007-1048, 4 p.Article
Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable GenomeTIEDEMANN, Rodger E; YUAN XAO ZHU; SCHMIDT, Jessica et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 3, pp 757-768, issn 0008-5472, 12 p.Article
Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agentsHONG WANG; HAIYONG HAN; MOUSSES, Spyro et al.Seminars in oncology. 2006, Vol 33, Num 4, pp 513-520, issn 0093-7754, 8 p.Article
New insights into testicular germ cell tumorigenesis from gene expression profilingSKOTHEIM, Rolf I; MONNI, Outi; MOUSSES, Spyro et al.Cancer research (Baltimore). 2002, Vol 62, Num 8, pp 2359-2364, issn 0008-5472Article
Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcomaGOKGOZ, Nalan; WUNDER, Jay S; MOUSSES, Spyro et al.Cancer. 2001, Vol 92, Num 8, pp 2181-2189, issn 0008-543XArticle
From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genomeMONNI, Outi; HYMAN, Elizabeth; MOUSSES, Spyro et al.Seminars in cancer biology. 2001, Vol 11, Num 5, pp 395-401, issn 1044-579XArticle
Functional evidence implicating S100P in prostate cancer progressionBASU, Gargi D; AZORSA, David O; KIEFER, Jeffrey A et al.International journal of cancer. 2008, Vol 123, Num 2, pp 330-339, issn 0020-7136, 10 p.Article
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingMOUSSES, Spyro; WAGNER, Urs; YIDONG CHEN et al.Oncogene (Basingstoke). 2001, Vol 20, Num 46, pp 6718-6723, issn 0950-9232Article
A transforming mutation in the pleckstrin homology domain of AKT1 in cancerCARPTEN, John D; FABER, Andrew L; UHLIK, Mark et al.Nature (London). 2007, Vol 448, Num 7152, pp 439-444, issn 0028-0836, 6 p.Article
Topoisomerase-IIα is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeSKOTHEIM, Rolf I; KALLIONIEMI, Anne; SMELAND, Sigbjørn et al.Journal of clinical oncology. 2003, Vol 21, Num 24, pp 4586-4591, issn 0732-183X, 6 p.Article
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancerRUIZ, Christian; HOLZ, David R; MOUSSES, Spyro et al.Journal of pathology (Print). 2011, Vol 223, Num 4, pp 543-552, issn 0022-3417, 10 p.Article
Differential subcellular expression of protein kinase C betall in breast cancer: correlation with breast cancer subtypesGÖKMEN-POLAR, Yesim; MEHTA, Rutika; BADVE, Sunil et al.Breast cancer research and treatment. 2010, Vol 124, Num 2, pp 327-335, issn 0167-6806, 9 p.Article
EphB2 expression across 138 human tumor types in a tissue microarray : High levels of expression in gastrointestinal cancersLUGLI, Alessandro; SPICHTIN, Hanspeter; MOUSSES, Spyro et al.Clinical cancer research. 2005, Vol 11, Num 18, pp 6450-6458, issn 1078-0432, 9 p.Article
Impact of DNA amplification on gene expression patterns in breast cancerHYMAN, Elizabeth; KAURANIEMI, Päivikki; KALLIONIEMI, Olli-P et al.Cancer research (Baltimore). 2002, Vol 62, Num 21, pp 6240-6245, issn 0008-5472, 6 p.Article
Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6TIEDEMANN, Rodger E; YUAN XIAO ZHU; FONSECA, Rafael et al.Blood. 2010, Vol 115, Num 8, pp 1594-1604, issn 0006-4971, 11 p.Article
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrayslMOUSSES, Spyro; BUBENDORF, Lukas; FERHLE, William et al.Cancer research (Baltimore). 2002, Vol 62, Num 5, pp 1256-1260, issn 0008-5472Article
RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5YUAN XIAO ZHU; TIEDEMANN, Rodger; KEITH STEWART, A et al.Blood. 2011, Vol 117, Num 14, pp 3847-3857, issn 0006-4971, 11 p.Article